TNF and brain neoplasm: Enhancers of BBTB permeability, such as the US-based approaches or NGR-TNF, or refined approaches exploiting RMT for drug delivery have yielded very promising results in preclinical studies and, in some cases, also in early-stage clinical studies in patients with brain tumors.